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INTRODUCTION:  Mycotic  pseudoaneurysms  of native  arteries  are rare.  Treatment  involves  arterial  excision
with  or  without  revascularization.
PRESENTATION OF  CASE:  A 49-year-old  diabetic  man  presented  with  a  4-month  history  of progressive
left  mid-thigh  pain,  associated  with  a  pulsatile  mass  and  fever.  Clinically,  he  appeared  to  have a  mycotic
pseudoaneurysm,  which  was conﬁrmed  by  computed  tomography.  The  aneurysm  was excluded  from
the  circulation  by  an extra-anatomical  bypass  graft using  autologous  vein.
CONCLUSION: Native  arterial  mycotic  pseudoaneurysms  typically  occur  in  immuno-compromised
patients. They  may  be  successfully  treated  using  autologous  vein  bypass.
DISCUSSION: Arterial  infection  is  associated  with  immunosuppressive  states  and  Staphylococcus  aureus
is  the  most  commonly  isolated  organism  in  mycotic  aneurysms.  Also,  Escherichia  coli,  Salmonella  sp.
and  anaerobic  species  have  been  identiﬁed.  Salmonella  species  are  associated  with  mycotic  aneurysms
in  the  abdominal  aorta  and  the  use of  autogenous  vein  grafts is  the standard  treatment  for  this  condition.
In  lower  extremities,  autogenous  conduits  have  been  already  used  with  good  results  of  patency  and
freedom  from  re-infection.  Endovascular  treatment  is  a  feasible  approach  in these  situations,  but  there
is  not  reports  regarding  long  term  results  and this  treatment  is  occasionally  associated  with  prosthesis
infection.
© 2011 Surgical Associates Ltd. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. . Introduction
Mycotic pseudoaneurysm is a consequence of arterial disrup-
ion by bacterial infection.1 Native arterial infection in the absence
f previous prostheses is rare. The intra-cranial arteries are the
ost common site of infection, followed by the aorta.2 Treatment
enerally involves arterial excision and in situ or extra-anatomical
evascularization. The use of lower-extremity deep and superﬁcial
eins to perform bypasses is reported, with satisfactory results.3
lternatively, endovascular stent deployment has low morbidity,
ut there are concerns regarding prosthesis infection and its conse-
uences (i.e., embolization, hemorrhage, and sepsis).4,5 We  report
 case of superﬁcial femoral artery mycotic pseudo-aneurysm
reated using extra-anatomical tunneled greater saphenous vein.. Case presentation
A  49-year-old diabetic man  presented with a 4-month history
f progressive left mid-thigh pain, associated with a mass and
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Open access under CC BYepisodes of fever. He had developed general weakness and weight
loss of 10 kg over the previous 6 months. There was no history of
lower-extremity trauma or illicit drug use. Physical examination
revealed a tender, warm,  erythematous pulsatile mass in the medial
left thigh. The femoral pulse was  normal, but the popliteal, dorsalis
pedis, and posterior tibial pulses were diminished. A computer-
ized tomography (CT) angiogram was performed (Fig. 1) which
conﬁrmed the clinical impression of a mycotic pseudoaneurysm.
Echocardiogram identiﬁed no cardiac vegetations. Duplex ultra-
sound examination of the contralateral greater saphenous vein
(GSV) demonstrated a venous diameter of 4.0 mm,  with no signs
of phlebitis. Laboratory exams revealed leukocytosis and hepati-
tis/HIV serology were negative. Empirical piperacillin–tazobactam
and vancomycin therapy was  initiated.
Surgery was performed the morning after admission. The pro-
cedure was initiated by lateral aspect popliteal artery dissection,
followed by common femoral artery isolation. The right GSV was
harvested and a subcutaneous lateral thigh tunnel was created.
Following systemic heparinisation, the origin of the superﬁcial
femoral artery (SFA) was ligated. The GSV was  implanted in a
non-reversed manner, and the valves were removed using Mills’
valvulotome after proximal anastomosis. Flow rate was estimated
as 450 mL/min. The graft was  tunneled and after distal anastomosis,
another ligature was placed in the popliteal artery. After complet-
ing the bypass, the incisions were closed and bandaged. Drainage
of the mass through another incision yielded a brownish air–liquid
-NC-ND license. 
CASE  REPORT  –  O
28 M.V.M. Cury et al. / International Journal of 
Fig. 1. Preoperative CT. Note the large pseudoaneurysm (black cross) and the asso-
ciated collection (white cross). The white arrow indicates greater saphenous vein.
Fig. 2. Postoperative CT angiogram (anterior and lateral view). Note the extra-
anatomical  position of the conduit in the left tight.
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In summary, we present a case of a mycotic pseudoaneurysm
of the superﬁcial femoral artery treated successfully with extra-
anatomic bypass using saphenous vein. We  believe that the use of
autologous vein is the best treatment option for arterial infection,ecretion that was sent for culture. During the drainage, SFA dis-
uption was noted and others ligatures were necessary to control
etrograde and collaterals hemorrhage, but blood transfusion was
ot necessary during the surgery or recovery.
The amplitudes of the popliteal and distal pulses were nor-
al after the procedure and the patient reported improvement of
he pain. Culture identiﬁed Salmonella sp. sensitive to ampicillin,
eftriaxone, and ciproﬂoxacin. Bypass patency was  demonstrated
n a control CT angiogram and no collections of pus were
etected near the native SFA, which was surgically occluded
Fig. 2).
The  patient was discharged one week postoperatively and
as prescribed ciproﬂoxacin for a further 8 weeks. The patient
as well clinically at discharge. There were no signs of infection
t the 2-week follow-up visit and incisions appeared satisfac-
ory. At 6 months follow-up, there were no signs of reinfection
nd a duplex ultrasound revealed that the bypass graft remains
atent.PEN  ACCESS
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3. Discussion
Iatrogenic and traumatic injuries are the main causes of
pseudoaneurysm.2 Mycotic aneurysms are rare, being associated
with intimal disruption and bacterial invasion with arterial infec-
tion. Therefore, this condition most commonly occurs at sites
of atherosclerotic plaques, aneurysms, and arterial bifurcations.6
Arterial infection is associated with immunosuppressive states
such as HIV infection, diabetes mellitus and active cancer.7,8
Staphylococcus aureus is the most commonly isolated organ-
ism in mycotic aneurysms, with Salmonella sp., Escherichia coli,
and anaerobic species also identiﬁed.2 Salmonella sp. are asso-
ciated with mycotic aneurysms in the thoracic and abdominal
aorta, especially in patients with HIV infection. Independent
of immunosuppressive disorders, a 6–8-week course of antibi-
otics is recommended and prophylactic cholecystectomy must be
considered.9
Illicit drug use is implicated in the development of mycotic
aneurysm. The condition occurs more commonly in the lower
extremities if the patient has used their leg veins in an attempt to
conceal needle puncture marks, or following previous thrombosis
or sclerosis of the arm veins. In these patients, the clinical manifes-
tations range from splinter hemorrhages to ischemic lesions caused
by digital emboli.10
In the aorta and iliac arteries, native or prosthetic graft infections
are generally treated by arterial or prosthesis excision, followed by
revascularization using veins. Clagett et al.11 reported satisfactory
results using deep and superﬁcial veins for aortic reconstruction.
In this situation, even extra-anatomical tunneled prostheses (e.g.,
axillo-bifemoral bypass graft) are associated with high rates of re-
infection (10–23%) and of failure (35%).12
Superﬁcial veins such as the greater saphenous vein have
been used as grafts for treatment of mycotic aneurysm in other
arterial segments, including the extra-cranial carotid artery.13 In
native common femoral artery (CFA) infections, Klonaris et al.14
reported satisfactory results using the internal iliac artery (IIA).
Their patients were intravenous drug users, and high-virulence
bacteria were identiﬁed (E. coli and S. aureus). Surgical treatment
involved dissection and removal of the IIA, which was then used as
a patch. Schneider et al.15 described the use of in situ deep-vein
grafts to treat superﬁcial femoral artery pseudoaneurysm. Even
when autologous vein is used, re-infection must be considered.
Ehsan and Gibbons16 advocated the use of per-operative broad-
spectrum antibiotics, followed by extensive arterial debridement
and creation of another tunnel where possible. Another treatment
option involves arterial ligation achieved by resection, but this type
of surgery is associated with a 34% incidence of signiﬁcant ischemia
necessitating major amputation.2
Endovascular treatment of aortic mycotic aneurysm has been
reported.17 This approach is favored because of the high morbid-
ity and mortality associated with conventional surgical treatment,
but stent infection, sepsis, and fatal complications must be
considered.18 It is suggested that endograft stenting is safe follow-
ing a course of antibiotics and negative blood cultures, but current
management suggests its use only in high-risk surgical patients.17
In other studies, Klonaris et al.19 reported hybrid, staged man-
agement of arterial infections in 6 patients with anastomotic
pseudoaneurysm who  were treated by endograft placement, fol-
lowed by secondary arterial debridement and vein-patch arterial
closure. Wales et al.20 reported a similar technique for extra-cranial
carotid artery pseudoaneurysm, but using an extra-anatomical
greater saphenous vein bypass graft.
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nd that creation of an extra-anatomical tunnel is associated with
ower re-infection rates.
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